- Scientists in Scotland have developed a pioneering new scanner aimed at improving treatment for glioblastoma, the most common and aggressive type of brain tumour.
- Field Cycling Imaging (FCI), a new technology derived from MRI, will be used by researchers at the University of Aberdeen and NHS Grampian after receiving £350,000 in funding from the Scottish Government.
- This unique scanner can track brain cancer spread by generating detailed images, working at low magnetic fields and detecting tumours without the need for injected dye.
- It is hoped FCI will differentiate between tumour growth and "pseudo-progression," allowing for more effective chemotherapy adjustments and preventing premature cessation of treatment.
- The technology aims to provide more accurate information for patients and clinicians, potentially improving quality of life, treatment effectiveness, and healthcare cost-effectiveness for glioblastoma patients.
IN FULL
‘Pioneering’ technology to be used on UK brain tumour patients in world-first